What are the roles of scientific journals and conferences in communicating research results?

Jun 27, 2018 ... This research study is being done to compare the effectiveness of either 15 or 30 mg once daily of upadacitinib versus adalimumab versus a placebo to control ... Nov 1, 2022 ... C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in ... Nov 2, 2017 ... Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial ... We calculated blinding indices in ... A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Lanadelumab for Prevention Against Acute ... May 15, 2020 ... Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. Dihydroergotamine nasal spray during migraine attacks: A double blind crossover study with placebo ... double-blind study. Cephalgia. 1984; 4:107-111. Jul 17, 2023 ... A double-blind study blinds both the subjects as well as the researchers to the treatment allocation. Jul 12, 2009 ... ... double-blind study in partial responders. A.C Altamura. ,. I Velonà. ,. R ... double-blind study, 28 patients with DSM-IV paranoid ... Sep 3, 2024 ... This is a randomized, placebo-controlled, double-blind multicenter, phase 2a study assessing the safety, pharmacokinetics (what the body does to ... A double-blind, randomized, prospective study was undertaken to determine if the dose of OKT3 used for induction immunosuppression following kidney and ...